Cargando…
mRNA vaccines for COVID-19 and diverse diseases
Since its outbreak in late 2019, the novel coronavirus disease 2019 (COVID-19) has spread to every continent on the planet. The global pandemic has affected human health and socioeconomic status around the world. At first, the global response to the pandemic was to isolate afflicted individuals to p...
Autores principales: | Hussain, Abid, Yang, Haiyin, Zhang, Mengjie, Liu, Qing, Alotaibi, Ghallab, Irfan, Muhammad, He, Huining, Chang, Jin, Liang, Xing-Jie, Weng, Yuhua, Huang, Yuanyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935967/ https://www.ncbi.nlm.nih.gov/pubmed/35331783 http://dx.doi.org/10.1016/j.jconrel.2022.03.032 |
Ejemplares similares
-
mRNA-based modalities for infectious disease management
por: Zhang, Mengjie, et al.
Publicado: (2022) -
Advances of mRNA vaccines for COVID-19: A new prophylactic revolution begins
por: Weng, Yuhua, et al.
Publicado: (2021) -
Efficient hepatic delivery and protein expression enabled by optimized mRNA and ionizable lipid nanoparticle
por: Yang, Tongren, et al.
Publicado: (2020) -
Ionizable lipid-assisted efficient hepatic delivery of gene editing elements for oncotherapy
por: Li, Chunhui, et al.
Publicado: (2021) -
Exosome regulation of immune response mechanism: Pros and cons in immunotherapy
por: Essola, Julien Milon, et al.
Publicado: (2023)